Page 6 - Read Online
P. 6

19         Efficacy and safety of immune checkpoint therapy in hepatocellular carcinoma: meta-analysis
                            Weina Tang, Long-Teng Ma, Yang Deng, Wei Wang, Hong-Wei Zhang
                            Hepatoma Res 2019;5:19  http://dx.doi.org/10.20517/2394-5079.2019.07


               20         Contrast-enhanced ultrasound with sulphur-hexafluoride in diagnosis of early HCC in cirrhosis
                            Antonio Giorgio, Pietro Gatti, Paolo Matteucci, Valentina Giorgio
                            Hepatoma Res 2019;5:20  http://dx.doi.org/10.20517/2394-5079.2019.05

               21         Three primary malignancies in 17 years in a man with chronic hepatitis B
                            Peter D. Block, Brianna J. Shinn, Christopher G. Roth, Jeffrey P. Baliff, Ralph G. Zinner, Hie-Won
                            Hann
                            Hepatoma Res 2019;5:21  http://dx.doi.org/10.20517/2394-5079.2019.17

               22         Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B
                            Peter D. Block, Brianna J. Shinn, Christopher G. Roth, Jeffrey P. Baliff, Ralph G. Zinner, Hie-Won
                            Hann
                            Hepatoma Res 2019;5:22  http://dx.doi.org/10.20517/2394-5079.2019.017


               23         Third time re-irradiation of liver metastasis with robotic radiosurgery: a case series
                            Debnarayan Dutta, Sathiya Krishnamoorthy, Rupa Das, Ram Madhavan, Haridas Nair, Raghavendra
                            Holla
                            Hepatoma Res 2019;5:23  http://dx.doi.org/10.20517/2394-5079.2019.09


               24         Advances in early diagnosis of hepatocellular carcinoma
                            Partha Pratim Bose, Urmimala Chatterjee
                            Hepatoma Res 2019;5:24  http://dx.doi.org/10.20517/2394-5079.2019.10


               25         Hepatocellular carcinoma occurred in a Hepatitis B carrier clinic cohort during a mean follow up
                            of 10 years
                            Cheng-Jen Chen, Jennifer Tai, Dar-In Tai
                            Hepatoma Res 2019;5:25  http://dx.doi.org/10.20517/2394-5079.2019.12

               26         Hepatocellular carcinoma: a new hope?
                            Lynn G. Feun
                            Hepatoma Res 2019;5:26  http://dx.doi.org/10.20517/2394-5079.2019.21


               27         Advances in surface markers of liver cancer stem cell
                            Jin-Liang Zhang, Lan-Qi Gong, Qian Yan, Ning-Ning Zhou, Victor Ho-Fun Lee, Xin-Yuan Guan
                            Hepatoma Res 2019;5:27  http://dx.doi.org/10.20517/2394-5079.2019.13


               28         Management of concomitant hepatocellular carcinoma and chronic hepatitis C: a review
                            Elizabeth Harrod, Carlos Moctezuma-Velazquez, Ahmet Gurakar, Aftab Ala, Douglas Dieterich,
                            Behnam Saberi
                            Hepatoma Res 2019;5:28  http://dx.doi.org/10.20517/2394-5079.2019.15
   1   2   3   4   5   6   7   8   9   10   11